Skip to main content
main-content

Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in oncology

Adis Journal Club

Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)

This article, featuring an infographic, details a head-to-head study comparing two neurokinin-1 receptor antagonists (fosnetupitant and fosaprepitant) for preventing chemotherapy-induced nausea and vomiting in patients with cancer. 
The featured article was funded by Helsinn Healthcare.

Expert discussion & interview

Early-stage NSCLC management – surgery, targeted treatment and immunotherapy

This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

New additions to the Adis Journal Club – May update

Browse May's selection of peer-reviewed articles from the Adis journal portfolio. Curated by the editors and updated monthly. These papers highlight topical research and reviews for the benefit of Medicine Matters readers.

Digital treatment map for ALK- and ROS1-mutated NSCLC

This independent content was supported by an educational grant from Pfizer.

Virtual Simulations

Treating patients with castration-sensitive prostate cancer

This activity is intended for US healthcare providers and was made possible by educational funding provided by Astellas Pharma.

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

IN FOCUS | Breast cancer

18-05-2022 | Breast cancer | News

ABC–DO shows poor breast cancer treatment compliance in sub-Saharan Africa

A high proportion of women with nonmetastatic breast cancer in sub-Saharan Africa do not initiate or complete treatment, show data from the African Breast Cancer–Disparities in Outcomes prospective cohort.

Podcasts

Interviews with clinical experts on cancer patient care

IN FOCUS | Lung & thoracic cancers

19-05-2022 | Small-cell lung cancer | News

CAPSTONE-1 demonstrates adebrelimab OS benefit for extensive-stage SCLC

Adding the PD-L1 inhibitor adebrelimab to first-line chemotherapy significantly extends overall survival for patients with extensive-stage small-cell lung cancer, Chinese investigators report.

  • » This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

IN FOCUS | Genitourinary cancers

10-05-2022 | Prostate cancer | News

Prostate cancer death linked to increases in BMI, waist size

A meta-analysis has identified a significantly elevated risk for prostate cancer-specific mortality with increases in BMI, waist circumference, and waist-to-hip ratio.

  • » This activity is intended for US healthcare providers and was made possible by educational funding provided by Astellas Pharma.

IN FOCUS | COVID-19 & cancer

24-02-2022 | ASCO GU 2022 | Conference coverage | Video

Mapping the impact of COVID-19 on genitourinary cancers

Chris Labaki takes us through his study evaluating temporal changes in the screening, diagnosis, and surgical treatment of genitourinary malignancies during the first year of the COVID-19 pandemic.

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox